Targeting proliferating cell nuclear antigen (PCNA) for cancer therapy
- 14 May 2024
- book chapter
- Published by Elsevier
- Vol. 100, 209-246
Abstract
No abstract availableKeywords
This publication has 146 references indexed in Scilit:
- Targeting PCNA with Peptide Mimetics for Therapeutic PurposesChemBioChem, 2019
- The PCNA interaction motifs revisited: thinking outside the PIP-boxCellular and Molecular Life Sciences, 2019
- The role of PCNA as a scaffold protein in cellular signaling is functionally conserved between yeast and humansFEBS Open Bio, 2018
- Tumor microenvironment and therapeutic responseCancer Letters, 2017
- Target validation and structure–activity analysis of a series of novel PCNA inhibitorsPharmacology Research & Perspectives, 2015
- Expression of a novel peptide derived from PCNA damages DNA and reverses cisplatin resistanceCancer Chemotherapy and Pharmacology, 2014
- Small molecule inhibitors of PCNA/PIP-box interaction suppress translesion DNA synthesisBioorganic & Medicinal Chemistry, 2013
- Proliferating cell nuclear antigen: a proteomics viewCellular and Molecular Life Sciences, 2008
- Inhibition of Cell Proliferation by the PCNA-Binding Region of p21 Expressed as a GFP MiniproteinExperimental Cell Research, 2001
- PCNA binding through a conserved motifBioEssays, 1998